DrugPatentWatch Database Preview
Eywa Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for EYWA, and what generic and branded alternatives to EYWA drugs are available?
EYWA has seven approved drugs.
Summary for Eywa
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 7 |
Drugs and US Patents for Eywa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eywa Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211556-002 | Oct 18, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Eywa Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211556-001 | Oct 18, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Eywa Pharma | URSODIOL | ursodiol | CAPSULE;ORAL | 212452-001 | Oct 30, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Eywa Pharma | BACLOFEN | baclofen | TABLET;ORAL | 211555-001 | Feb 1, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
